Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2014

Open Access 01-12-2014 | Research article

Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65

Published in: BMC Musculoskeletal Disorders | Issue 1/2014

Login to get access

Abstract

Background

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease mediated by T cells. The aim of the present study was to investigate the therapeutic efficacy of synthetic peptides (HP-R1, HP-R2 and HP-R3), derived from the sequence of 65-kD mycobacterial heat shock protein (HSP), in the treatment of RA using adjuvant-induced arthritis (AA) animal model.

Methods

AA was induced by a single intradermal injection Freund’s complete adjuvant in male Lewis rats. At the first clinical sign of disease, rats were administered nasally by micropipette of peptides or phosphate buffer saline (PBS). Disease progression was monitored by measurement of body weight, arthritis score and paw swelling. The changes of histopathology were assessed by hematoxylin eosin staining. The serum levels of tumor necrosis factor (TNF) - alpha and interleukin (IL)-4 were measured by enzyme-linked immunosorbent assay (ELISA).

Results

The peptides efficiently inhibited the footpad swelling and arthritic symptoms in AA rats. The synthetic peptides displayed significantly less inflammatory cellular infiltration and synovium hyperplasia than model controls. This effect was associated with a suppression of pro-inflammatory cytokine TNF-alpha production and an increase of anti-inflammatory cytokine IL-4 production after peptides treatment.

Conclusions

These results suggest that the synthetic peptides derived from HSP65 induce highly effective protection against AA, which is mediated in part by down-regulation of inflammatory cytokines, and support the view that the synthetic peptides is a potential therapy for RA that may help to diminish both joint inflammation and destruction.
Appendix
Available only for authorised users
Literature
1.
Hobl EL, Mader RM, Erlacher L, Duhm B, Mustak M, Broll H, Hogger P, Kalipciyan M, Jilma B: The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Clin Exp Rheumatol. 2011, 29 (6): 963-969.PubMed
2.
McInnes IB, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007, 7 (6): 429-442.CrossRefPubMed
3.
Christodoulou C, Choy EH: Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med. 2006, 6 (1): 13-19.CrossRefPubMed
4.
Rao P, Knaus EE: Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008, 11 (2): 81s-110s.CrossRefPubMed
5.
White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM: Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol. 2007, 99 (1): 91-98.CrossRefPubMed
6.
Zarraga IG, Schwarz ER: Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol. 2007, 49 (1): 1-14.CrossRefPubMed
7.
Venkatesha SH, Rajaiah R, Berman BM, Moudgil KD: Immunomodulation of autoimmune arthritis by herbal CAM. Evid Based Complement Alternat Med. 2011, 2011: 986797-CrossRefPubMed
8.
Prakken BJ, Roord S, Van Kooten PJ, Wagenaar JP, Van Eden W, Albani S, Wauben MH: Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum. 2002, 46 (7): 1937-1946.CrossRefPubMed
9.
Zhou J, Wang LP, Feng X, Fan DD, Zang WJ, Wang B: Synthetic peptides from heat-shock protein 65 inhibit proinflammatory cytokine secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients. Clin Exp Pharmacol Physiol. 2014, 41 (1): 67-72.CrossRefPubMed
10.
Roord ST, Zonneveld-Huijssoon E, Le T, Yung GP, Koffeman E, Ronaghy A, Ghahramani N, Lanza P, Billetta R, Prakken BJ, Albani S: Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis. PLoS One. 2006, 1: e87-CrossRefPubMedPubMedCentral
11.
Naidu VG, Dinesh BK, Thwin MM, Satish RL, Kumar PV, Gopalakrishnakone P: RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-kappaB activation and down regulating inflammatory cytokines. Chem Biol Interact. 2013, 203 (2): 467-479.CrossRefPubMed
12.
Rajaiah R, Lee DY, Ma Z, Fan AY, Lao L, Fong HH, Berman BM, Moudgil KD: Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation. J Ethnopharmacol. 2009, 123 (1): 40-44.CrossRefPubMedPubMedCentral
13.
Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, Berman BM, Moudgil KD: Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. J Nutr. 2008, 138 (11): 2111-2116.CrossRefPubMedPubMedCentral
14.
Durai M, Kim HR, Bala KK, Moudgil KD: T cells against the pathogenic and protective epitopes of heat-shock protein 65 are crossreactive and display functional similarity: novel aspect of regulation of autoimmune arthritis. J Rheumatol. 2007, 34 (11): 2134-2143.PubMed
15.
Hussein YM, El-Shal AS, Rezk NA, Abdel GS, Alzahrani SS: Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population. Cytokine. 2013, 61 (3): 849-855.CrossRefPubMed
16.
Dimitrova P, Skapenko A, Herrmann ML, Schleyerbach R, Kalden JR, Schulze-Koops H: Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol. 2002, 169 (6): 3392-3399.CrossRefPubMed
17.
Meugnier E, Coury F, Tebib J, Ferraro-Peyret C, Rome S, Bienvenu J, Vidal H, Sibilia J, Fabien N: Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments. Physiol Genomics. 2011, 43 (7): 365-371.CrossRefPubMed
18.
Rifkin LM, Birnbaum AD, Goldstein DA: TNF inhibition for ophthalmic indications: current status and outlook. Biodrugs. 2013, 27 (4): 347-357.CrossRefPubMed
19.
Page TH, Brown A, Timms EM, Foxwell BM, Ray KP: Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?. Arthritis Rheum. 2010, 62 (11): 3221-3231.CrossRefPubMed
20.
Balsa A, Del AJ, Blanco F, Caliz R, Silva L, Sanmarti R, Martinez FG, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Collado MD, Andreu JL, Graell E, Simón L, Martínez A, Mulero J: Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. Rheumatology (Oxford). 2010, 49 (3): 458-466.CrossRef
21.
22.
23.
Gerli R, Lunardi C, Pitzalis C: Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis. Rheumatology (Oxford). 2002, 41 (12): 1341-1345.CrossRef
24.
Prakken BJ, van der Zee R, Anderton SM, Van Kooten PJ, Kuis W, Van Eden W: Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A. 1997, 94 (7): 3284-3289.CrossRefPubMedPubMedCentral
25.
Haque MA, Yoshino S, Inada S, Nomaguchi H, Tokunaga O, Kohashi O: Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur J Immunol. 1996, 26 (11): 2650-2656.CrossRefPubMed
26.
Lorenzo N, Barbera A, Dominguez MC, Torres AM, Hernandez MV, Hernandez I, Gil R, Ancizar J, Garay H, Reyes O, Altruda F, Silengo L, Padrón G: Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. Autoimmunity. 2012, 45 (6): 449-459.CrossRefPubMed
27.
Wauben MH: Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases. Crit Rev Immunol. 2000, 20 (6): 451-469.CrossRefPubMed
Metadata
Title
Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65
Publication date
01-12-2014
Published in
BMC Musculoskeletal Disorders / Issue 1/2014
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-15-253

Other articles of this Issue 1/2014

BMC Musculoskeletal Disorders 1/2014 Go to the issue

Research article

RETRACTED ARTICLE: Open reduction and closed reduction internal fixation in treatment of femoral neck fractures: a meta-analysis

Research article

Natural history of hip instability in infants (without subluxation or dislocation): a three year follow-up

Research article

The influence of knee position on ankle dorsiflexion - a biometric study

Research article

Hyaluronic acid enhances the effect of the PAMPS/PDMAAm double-network hydrogel on chondrogenic differentiation of ATDC5 cells

Research article

An update of stabilisation exercises for low back pain: a systematic review with meta-analysis

Research article

Are outcomes after total knee arthroplasty worsening over time? A time-trends study of activity limitation and pain outcomes